Document Type

Article

Department or Administrative Unit

Chemistry

Publication Date

12-17-2014

Abstract

The first total synthesis of the potent and selective human blood coagulation factor XIa inhibitor clavatadine A (1) is described. Direct, early-stage guanidinylation enabled rapid, convergent access to an immediate clavatadine A precursor. Concomitant lactone hydrolysis and guanidine deprotection with aqueous acid cleanly provided clavatadine A (1) in only four steps (longest linear sequence, 41–43% overall yield).

Comments

This article was originally published in Journal of Natural Products with an ACS AuthorChoice License. The full-text article from the publisher can be found here.

Journal

Journal of Natural Products

Rights

Copyright © 2014 The American Chemical Society and American Society of Pharmacognosy

Share

COinS